Publication: Switch to subsequent line of treatment in children and adolescents with chronic myeloid leukemia (CML) treated with imatinib: Experience of the international registry for chronic myeloid leukemia in children and adolescents (I-CML-Ped Study)
dc.contributor.author | Millot, Frederic | |
dc.contributor.author | Guilhot, Joelle | |
dc.contributor.author | Suttorp, Meinolf | |
dc.contributor.author | Meunier, Anne Sophie | |
dc.contributor.author | Meral, Güneş Adalet | |
dc.contributor.author | Sedlacek, Petr | |
dc.contributor.author | de Bont, Eveline | |
dc.contributor.author | Li, Chi Kong | |
dc.contributor.author | Kalwak, Krzysztof | |
dc.contributor.author | Lausen, Birgitte | |
dc.contributor.author | Culic, Srdjana | |
dc.contributor.author | De Moerloose, Barbara | |
dc.contributor.author | Biondi, Andrea | |
dc.contributor.author | Baruchel, Andre | |
dc.contributor.buuauthor | MERAL GÜNEŞ, ADALET | |
dc.contributor.department | Uludağ Üniversitesi/Tıp Fakültesi/Çocuk Hematoloji Anabilim Dalı. | |
dc.contributor.researcherid | IMO-4290-2023 | |
dc.date.accessioned | 2024-07-30T08:42:53Z | |
dc.date.available | 2024-07-30T08:42:53Z | |
dc.date.issued | 2015-12-03 | |
dc.description | Bu çalışma, 05-08, Aralık 2015 tarihlerinde Orlando[Amerika]’da düzenlenen 57th Annual Meeting of the American-Society-of-Hematology Kongresi‘nde bildiri olarak sunulmuştur. | |
dc.description.sponsorship | Amer Soc Hematol | |
dc.identifier.issn | 0006-4971 | |
dc.identifier.issue | 23 | |
dc.identifier.uri | https://hdl.handle.net/11452/43542 | |
dc.identifier.volume | 126 | |
dc.identifier.wos | 000368019005054 | |
dc.indexed.wos | WOS.SCI | |
dc.indexed.wos | WOS.ISTP | |
dc.language.iso | en | |
dc.publisher | Amer Soc Hematology | |
dc.relation.journal | Blood | |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi | |
dc.rights | info:eu-repo/semantics/closedAccess | |
dc.subject | Hematology | |
dc.title | Switch to subsequent line of treatment in children and adolescents with chronic myeloid leukemia (CML) treated with imatinib: Experience of the international registry for chronic myeloid leukemia in children and adolescents (I-CML-Ped Study) | |
dc.type | Meeting Abstract | |
dspace.entity.type | Publication | |
relation.isAuthorOfPublication | 500825a8-5e0f-481f-a84f-d7fb8759c049 | |
relation.isAuthorOfPublication.latestForDiscovery | 500825a8-5e0f-481f-a84f-d7fb8759c049 |